Efficacy and bleeding risk of antithrombin supplementation in septic disseminated intravascular coagulation: a secondary survey

INTRODUCTION: In a previous report, we demonstrated a favorable trend for supplementation with antithrombin (AT) concentrate at a dosage of 3,000 IU/day over 1,500 IU/day for the treatment of sepsis-associated disseminated intravascular coagulation (DIC) in patients with an AT activity of 70% or les...

Descripción completa

Detalles Bibliográficos
Autores principales: Iba, Toshiaki, Saitoh, Daizoh, Wada, Hideo, Asakura, Hidesaku
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4182824/
https://www.ncbi.nlm.nih.gov/pubmed/25220851
http://dx.doi.org/10.1186/s13054-014-0497-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4182824/
https://www.ncbi.nlm.nih.gov/pubmed/25220851
http://dx.doi.org/10.1186/s13054-014-0497-x

Ejemplares similares